In a large multi-cohort plasma study including 574 ALS patients across four independent populations, elevated levels of secreted phosphoprotein 1 (SPP1) at diagnosis consistently predicted shorter survival. Here, SPP1 is linked to amyotrophic lateral sclerosis.